Vivesto Stock

Vivesto Enterprise Value

The Enterprise Value (EV) of Vivesto (VIVE.ST) as of Aug 10, 2026 is 13.40 M SEK. In the previous year, Enterprise Value (EV) was -43.91 M SEK — a change of -130.52% (higher).

Enterprise Value

13.40 MSEK

YoY

-130.52%

Last updated:

Enterprise Value (EV) of Vivesto is 2026 13.40 M SEK. Enterprise Value (EV) of Vivesto was 2025 -43.91 M SEK. It decreases by -130.52% higher compared to the previous year.
Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

Enterprise Value (EV) of Vivesto is 13.40 M SEK in 2026.

Enterprise Value (EV) of Vivesto changed from -43.91 M SEK to 13.40 M SEK, representing a -130.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Vivesto since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s SEK, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' SEK varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Vivesto with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Vivesto

All Key Metrics — Vivesto